e.l.f. Beauty Q2 FY2027 earnings review
Quarter ended September 30, 2026
For information only, not investment advice. No rating or price target.
Net sales rose 51% to $520.8M and beat consensus by 11%.
e.l.f. Beauty · Q2 FY2027 · Published Nov 4, 2026 · By DeepCell AI · Sources
Quarter ended September 30, 2026
For information only, not investment advice. No rating or price target.
Built with DeepCell / deepcell.net
1 · e.l.f. Beauty (ELF) Q2 FY2027 earnings review
Note: After-hours price is at 4:27 PM ET, not a close. Consensus is from LSEG (via CNBC) and MarketBeat.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; LSEG consensus via CNBC, Nov 4, 2026; Yahoo Finance prices, Nov 3–4, 2026
2 · Executive summary
Q2 FY2027 results vs. consensus (LSEG via CNBC; MarketBeat, Nov 4, 2026)
| Metric | Actual | Consensus | Variance | Result |
|---|---|---|---|---|
| Net sales (LSEG) | $520.8M | $470.3M | +$50.5M / +10.7% | Beat |
| Adjusted EPS (LSEG) | $1.21 | $0.60 | +$0.61 / +101.7% | Beat |
| Net sales (MarketBeat) | $520.8M | $473.5M | +$47.3M / +10.0% | Beat |
| Adjusted EPS (MarketBeat) | $1.21 | $0.595 | +$0.615 / +103.4% | Beat |
Share price, Nov 3–4, 2026 (Yahoo Finance)
| e.l.f. Beauty (NYSE) | Nov 3 close | Nov 4 close | Nov 4 after-hours | After-hours move |
|---|---|---|---|---|
| ELF | $111.50 | $113.63 | $116.50 | +2.5% |
After-hours price at 4:27 PM ET, Nov 4: after-hours, not a close. Move is versus the Nov 4 close.
Note: Adjusted EPS excludes stock pay, the rhode earnout change and acquired intangible amortization. GAAP diluted EPS was $0.50.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; CNBC (LSEG), Nov 4, 2026; MarketBeat, Nov 4, 2026; Yahoo Finance prices
3 · Q2 results vs. consensus
FY2027 outlook, updated Nov 4, 2026
| Metric | Prior | Updated | Updated midpoint | Midpoint raise |
|---|---|---|---|---|
| Net sales ($M) | $1,938M to $1,968M | $2,003M to $2,029M | $2,016M | +3.2% |
| Adjusted EBITDA ($M) | $401M to $407M | $421M to $427M | $424M | +5.0% |
| Adjusted net income ($M) | $212M to $215M | $231M to $233M | $232M | +8.7% |
| Adjusted diluted EPS ($) | $3.50 to $3.55 | $3.82 to $3.86 | $3.84M | +8.9% |
Implied second half, at updated midpoints
| Metric | First half | Implied second half |
|---|---|---|
| Net sales ($M) | $1,000M | $1,016M |
| Adjusted EBITDA ($M) | $292M | $132M |
| Adjusted diluted EPS ($) | $2.96 | $0.88 |
Note: Updated net sales growth is 22% to 24%. Tax rate (25% to 26%) and 60.5M shares are unchanged. No FY27 consensus was verified.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
4 · FY2027 outlook
Key figures
| $M unless noted | Q2 FY2026 | Q2 FY2027 | YoY |
|---|---|---|---|
| Net sales | $343.9M | $520.8M | 51.4% |
| Gross profit | $238.9M | $370.2M | 55.0% |
| Adjusted EBITDA | $66.2M | $123.4M | 86.2% |
| Adjusted net income | $40.7M | $72.7M | 78.4% |
| Adjusted diluted EPS | $0.68 | $1.21 | 77.9% |
Note: The rhode earnout charge reflects rhode revenue running ahead of earnout thresholds.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
5 · Q2 key financials
Note: The release gives no channel or brand split of net sales.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
6 · Sales and cost lines
Operating income bridge
$M, Q2 FY2026 to Q2 FY2027
Note: Steps are each line’s change. Totals are reported operating income.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
7 · Operating income bridge
Note: About 520 bps of the first-half gross margin gain came from IEEPA tariff refunds.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
8 · First-half results
Note: D and A is depreciation and amortization. Other items are cloud software amortization, acquisition and ERP costs.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
9 · Net income to EBITDA
Note: Adjusted EBITDA margin is Adjusted EBITDA divided by net sales.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
10 · Margin analysis
Operating cash flow to change in cash
$M, 6M FY2027
Note: The release gives cash flows for six months only, not for Q2 alone.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
11 · First-half cash flow
Cost lines to net sales
%, Q2 FY2026 vs. Q2 FY2027
Note: Adjusted SG&A excludes stock pay, ERP and acquisition costs.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
12 · Operating cost ratios
Note: The release states total debt of $826.7M at Sep 30, 2026; book values are shown here.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
13 · Balance sheet
Note: These are analytical watch points, not company targets.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
14 · Key risks to guidance
| Claim | Evidence | Calculation |
|---|---|---|
| Operating margin rose | 2.2% to 10.1% | Operating income to sales |
| Adjusted net margin rose | 11.8% to 14.0% | Adjusted net income to sales |
| GAAP diluted EPS rose | $0.05 to $0.50 | Statements of operations |
| Adjusted net income rose | $40.7M to $72.7M | Non-GAAP reconciliation |
| Acquired intangible amortization | $8.9M to $11.1M | Non-GAAP reconciliation |
| Income tax | ($7.0M) to $13.0M | Prior year was a benefit |
Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
15 · Appendix: Profit detail
| Claim | Evidence | Calculation |
|---|---|---|
| Net sales rose | $697.7M to $1,000.2M | 6M FY2027 |
| Gross margin rose | 69% to 77% | Gross profit to sales |
| Adjusted net income rose | $92.1M to $177.2M | 6M FY2027 |
| Adjusted EPS rose | $1.57 to $2.96 | 6M FY2027 |
| Free cash flow rose | $36.7M to $122.3M | Operating cash less capex |
| Capital spending fell | $13.9M to $4.0M | Property and equipment |
6M is six months. Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
16 · Appendix: First half
| Claim | Evidence | Calculation |
|---|---|---|
| Updated net sales growth | 22% to 24% | Prior was 18% to 20% |
| Adjusted EBITDA midpoint raise | +5.0% | Updated vs prior |
| Adjusted net income midpoint | $232M | Updated outlook |
| Implied H2 adjusted net income | $54.8M | Midpoint less first half |
| Implied H2 net sales | $1,015.8M | Midpoint less first half |
| Diluted shares outlook | 60.5M | Unchanged |
Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
17 · Appendix: Guidance detail
| Claim | Evidence | Calculation |
|---|---|---|
| Accounts receivable | $174.6M to $246.2M | Mar 31 to Sep 30 |
| Inventory | $220.2M to $260.6M | Mar 31 to Sep 30 |
| Total assets | $2,394.2M to $2,567.2M | Mar 31 to Sep 30 |
| Total liabilities | $1,263.6M to $1,341.7M | Mar 31 to Sep 30 |
| Stockholders equity | $1,130.5M to $1,225.5M | Mar 31 to Sep 30 |
| Total debt per release | $826.7M | Sep 30, 2026, principal basis |
Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
18 · Appendix: Balance detail
Income statement lines, $M and YoY %
| $M unless noted | Q2 FY2026 | Q2 FY2027 | YoY |
|---|---|---|---|
| Net sales | $343.9M | $520.8M | 51.4% |
| Gross profit | $238.9M | $370.2M | 55.0% |
| SG&A | $231.1M | $300.1M | 29.8% |
| Operating income | $7.7M | $52.4M | 579.4% |
| Net income | $3.0M | $30.0M | 902.3% |
Net income to Adjusted EBITDA, $M
| $M | Q2 FY2026 | Q2 FY2027 |
|---|---|---|
| Net income | $3.0M | $30.0M |
| Interest and taxes | $2.2M | $23.0M |
| Depreciation and amortization | $18.3M | $24.1M |
| Stock-based compensation | $29.5M | $24.6M |
| Adjusted EBITDA | $66.2M | $123.4M |
Note: Adjusted EBITDA also adds back the earnout change, debt extinguishment loss and other items.Source: e.l.f. Beauty Form 8-K press release, Nov 4, 2026; analysis of company data
19 · Appendix: P&L and EBITDA
Built with DeepCell / deepcell.net
20 · Sources
For information only. This presentation is provided for information only. It is not investment, legal, tax or accounting advice, and it is not an offer, or a solicitation of an offer, to buy or sell any security.
No recommendation. It carries no rating, price target or buy, sell or hold view, and it was prepared without regard to any reader's investment objectives, financial situation or needs.
Sources and accuracy. Company figures come from e.l.f. Beauty's Form 8-K of November 4, 2026 (Exhibit 99.1). Consensus estimates (LSEG via CNBC, MarketBeat) and share prices (Yahoo Finance) are third-party data, credited on the sources page. We have not independently verified third-party data.
Basis of presentation. Figures are as reported for the quarters ended September 30, 2026 and 2025, in US dollars. e.l.f. Beauty's fiscal year ends March 31.
Forward-looking statements. Company guidance, consensus estimates and the watch items in this deck are forward-looking. They rest on assumptions that may prove wrong, and actual results may differ materially.
Non-GAAP measures. Adjusted EBITDA, adjusted SG&A, adjusted net income and adjusted EPS follow e.l.f. Beauty's own definitions and are reconciled to GAAP in its release. They may not be comparable with other companies' measures.
No liability. No liability is accepted for any direct or indirect loss arising from the use of this presentation or its contents.
No affiliation. This presentation is not affiliated with, reviewed or endorsed by e.l.f. Beauty, Inc. Company and brand names belong to their owners.
How it was made. The deck was built with DeepCell, with figures linked to a model in the file. Readers should check the figures against the original filings.
Date of analysis. The analysis reflects information available shortly after the November 4, 2026 release. The after-hours price is not a close.
Built with DeepCell / deepcell.net
21 · Disclosures
Not investment advice; no rating or price target.
Built in DeepCell Every figure on these slides opens its formula and its source. See how a review like this is made.
Send the link: it opens with the picture below, and every number on the page still opens its formula and source. The picture is free to download and share.
Coherent · Q1 FY2027
Non-GAAP EPS of $2.09 beat consensus, and Q2 guidance sits above it.
Nov 4, 202621 slides
MercadoLibre · Q3 2026
Revenues rose 45.1%, but EPS of $8.83 missed consensus as margins fell.
Nov 4, 202621 slides
Qualcomm · Q4 FY2026
Non-GAAP EPS of $2.17 beat LSEG, but Q1 EPS guidance sits below consensus.
Nov 4, 202621 slides
Arm Holdings · Q2 FY2027
Revenue rose 27% to $1,443M and beat consensus by 5%.
Nov 4, 202621 slides
Zillow Group · Q3 2026
Revenue rose 7% to $724M but missed consensus by 4%.
Nov 4, 202621 slides